A gene expression signature of MEK pathway activation to predict survival in triple-negative breast cancer.

被引：0
|
作者：
Balko, Justin M.
Sanders, Melinda
Gabriela Kuba, Maria
Pinto, Joseph A.
Doimi, Franco F.
Leonidas Gomez, Henry
Arteaga, Carlos L.
机构：
[1] Vanderbilt Univ, Nashville, TN USA
[2] Vanderbilt Ingram Canc Ctr, Nashville, TN USA
[3] Oncosalud, Div Invest, Lima, Peru
[4] Inst Nacl Enfermedades Neoplas, Lima, Peru
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1024
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Tumor microenvironment characterization in triple-negative breast cancer identifies prognostic gene signature
    Qin, Yan
    Deng, Jiehua
    Zhang, Lihua
    Yuan, Jiaxing
    Yang, Huawei
    Li, Qiuyun
    [J]. AGING-US, 2021, 13 (04): : 5485 - 5505
  • [42] A gene signature predicts response to neoadjuvant chemotherapy in triple-negative breast cancer patients
    Zheng, Tianzhi
    Pang, Zhiyuan
    Zhao, Zhao
    [J]. BIOSCIENCE REPORTS, 2019, 39
  • [43] Higher peripheral lymphocyte count to predict survival in triple-negative breast cancer (TNBC).
    Afghahi, Anosheh
    Rigdon, Joseph
    Purington, Natasha
    Desal, Manisha
    Pierson, Emma
    Mathur, Maya
    Thompson, Caroline A.
    Curtis, Christina
    West, Robert B.
    Horst, Kathleen C.
    Gomez, Scarlett Lin
    Ford, James M.
    Sledge, George W.
    Kurian, Allison W.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [44] Triple-Negative Breast Cancer: A Comparison of Race and Survival
    Doepker, Matthew P.
    Holt, Scott D.
    Durkin, Martin W.
    Chu, Christopher H.
    Nottingham, James M.
    [J]. AMERICAN SURGEON, 2018, 84 (06) : 881 - 888
  • [45] Sulforaphane suppresses metastasis of triple-negative breast cancer cells by targeting the RAF/MEK/ERK pathway
    Zhang, Ying
    Lu, Qian
    Li, Nan
    Xu, Ming
    Miyamoto, Tatsuo
    Liu, Jing
    [J]. NPJ BREAST CANCER, 2022, 8 (01)
  • [46] Sulforaphane suppresses metastasis of triple-negative breast cancer cells by targeting the RAF/MEK/ERK pathway
    Ying Zhang
    Qian Lu
    Nan Li
    Ming Xu
    Tatsuo Miyamoto
    Jing Liu
    [J]. npj Breast Cancer, 8
  • [47] Kindlin-1 expression is associated with EGFR/RAS/MAPK activation and response to MEK inhibitors in triple-negative breast cancer
    Azorin, Paula
    Bonin, Florian
    Tariq, Zakia
    Coussy, Florence
    Marangoni, Elisabetta
    Lidereau, Rosette
    Driouch, Keltouma
    [J]. CANCER RESEARCH, 2020, 80 (16)
  • [48] Mesothelin expression and survival outcomes in triple-receptor negative breast cancer.
    Parinyanitikul, Napa
    Blumenschein, George R.
    Wu, Yun
    Lei, Xiudong
    Gregor, Mariana Chavez-Mac
    Smart, Melody L.
    Gonzalez-Angulo, Ana M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [49] Prediction of Recurrence and Survival for Triple-Negative Breast Cancer (TNBC) by a Protein Signature in Tissue Samples
    Campone, Mario
    Valo, Isabelle
    Jezequel, Pascal
    Moreau, Marie
    Boissard, Alice
    Campion, Loic
    Loussouarn, Delphine
    Verriele, Veronique
    Coqueret, Olivier
    Guette, Catherine
    [J]. MOLECULAR & CELLULAR PROTEOMICS, 2015, 14 (11) : 2936 - 2946
  • [50] SLC1A5 to predict outcome with chemotherapy in early triple-negative breast cancer.
    Affan, Anna Maria
    Varadan, Vinay
    Gilmore, Hannah L.
    Miskimen, Kristy
    Jeon, Young Joo
    Parsai, Shikha
    Ronai, Ze'ev
    Harris, Lyndsay
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345